ObamaCare Could Have a Big Impact on the Market for Drugs. But Will It Be Positive or Negative?

Potential shortfalls in enrollment for President Barack Obama‘s health-care overhaul would put a 30 percent dent in projections for U.S. prescription-drug sales in 2017, a report from IMS Health Inc. shows. That worst-case scenario would translate to $320 billion in drug spending, according to the report. The best case is supposed to be $460 billion, [...]



via John Goodman's Health Policy Blog http://healthblog.ncpa.org/obamacare-could-have-a-big-impact-on-the-market-for-drugs-but-will-it-be-positive-or-negative/